Newsletter

Int. Rev. Allergol. Clin. Immunol. Family Med., 2019, XXV/4: 151-154 Maximize

Int. Rev. Allergol. Clin. Immunol. Family Med., 2019, XXV/4: 151-154

Title: Antimalarial chemoprophylaxis for travellers 

Authors: Korzeniewski K, Pokorna-Kałwak D. 

More details

02-04-2019

0,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN ENGLISH.

Antimalarial chemoprophylaxis for travellers


Korzeniewski K1, Pokorna-Kałwak D2.

1Department of Epidemiology and Tropical Medicine, Military Institute of Medicine, Warsaw, Poland; 2Department Family Medicine, Medical University, Wrocław, Poland

International Review of Medical Practice, 2019; Vol. 25, No. 4, 151

Travel to hot climate countries in Asia, Africa and South America has become increasingly popular in recent years. Destinations where malaria is endemic are also growing in popularity among tourists. Malaria, a parasitic disease transmitted by mosquitoes, is a major health issue both among the local populations as well as among immigrants and tourists. In the developed countries of North America and Europe there are practically no reports of the indigenous cases, however, thousands of cases are imported into these countries from endemic regions, mainly from the countries with tropical or subtropical climate. A certain number of malaria cases have also been reported in Poland, these cases are usually travel-related and exported from Africa or Asia. The risk for developing the disease depends on the destination as well as the compliance (or non-compliance) with antimalarial chemoprophylaxis. The article provides information on prophylactic measures which may prevent the export of malaria to the traveller’s home country.

Key words: travel medicine, health prevention, malaria